IDH3A and neoplasm: IDH3α reduction results in accumulation of HIF-1α, promoting glycolysis of CAFs by increasing glucose uptake and upregulation of glycolytic enzymes under normoxic conditions [113], indicating that IDH3α exerts its pro-tumor role by enhancing RWE in CAFs; this process is regulated by TGF-β signaling.